The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Factors such as the introduction of innovative treatment options, rising disposable incomes ... such as diabetic retinopathy and computer vision syndrome, is contributing to market expansion.

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

According to experts, soon the integration of artificial intelligence (AI) into healthcare will drastically shift from a novelty, to a critical resource. With over 800 FDA-cleared health AI ...

From a 14-year-old innovator in Frisco to an up-and-coming healthcare C-Suiter, these five up-and-comers are driving change ...

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 17, 2025 /PRNewswire/ -- According to experts, soon the integration of artificial intelligence ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

Early detection and monitoring are key to the diagnosis and management of ocular diseases, including glaucoma, retinal and ...